ZACKS RESEARCH

FUNDS

PORTFOLIO

BROKER RESEARCH

MARKETS

SCREENING

EDUCATION

SERVICES

Earnings

EPS Surprises

Mutual Funds

Options

My Account

Help

What's Up With These Ridiculous Stock Gains?

Steve Reitmeister didn't want me to tell you this. He felt that one strategy's performance stands out so much that... Read on >>

Quote:

Search for Ticker

Free Membership

Search:

USNA: Usana Health Sciences Inc - Full Company Report Enter Ticker:

Quote	Estimates	Charts	Company Reports	News	Financials

Full Company Report \| Estimates \| Brokerage Recommendations \| Comparison to Industry \| Insiders \| Brokerage Reports \| Zacks Equity Research \| Annual Report

USANA HEALTH SCIENCES INC (NASD)
USNA	32.39	-0.26	(-0.80%)	Vol. 5,136	10:38 ET

USANA Health Sciences Inc. develops and manufactures high-quality nutritional, personal care and weight management products. The company's three primary product lines consist of nutritional, personal care and weight management products. The company's products are distributed primarily through a network marketing system.

General Information

USANA HLTH SCI

3838 West Parkway Boulevard Salt Lake City, UT 84120 Phone: 801 954-7100 Fax: 801 954-7300 Web: www.usanahealthsciences.com Email: investor.relations@us.usana.com

Industry	MED-DRUGS
Sector:	Medical

Fiscal Year End	December
Last Reported Quarter	09/30/09
Next EPS Date	02/22/2010

Price and Volume Information

Zacks Rank
Yesterday's Close	32.65
52 Week High	37.19
52 Week Low	17.72
Beta	0.79
20 Day Moving Average	57,099.95
Target Price Consensus	38.33

% Price Change
4 Week	-11.40
12 Week	6.49
YTD	-4.64

% Price Change Relative to S&P 500
4 Week	-14.78
12 Week	-3.87
YTD	-23.47

Share Information
Shares Outstanding (millions)	15.53
Market Capitalization (millions)	507.22
Short Ratio	18.39
Last Split Date	10/31/2003

Dividend Information
Dividend Yield	0.00%
Annual Dividend	$0.00
Payout Ratio	0.00
Change in Payout Ratio	0.00
Last Dividend Payout / Amount	NA / $0.00

EPS Information
Current Quarter EPS Consensus Estimate	0.59
Current Year EPS Consensus Estimate	2.10
Estimated Long-Term EPS Growth Rate	18.00
Next EPS Report Date	02/22/2010

Consensus Recommendations
Current (1=Strong Buy, 5=Strong Sell)	2.20
30 Days Ago	2.60
60 Days Ago	3.00
90 Days Ago	3.17

Fundamental Ratios

P/E
Current FY Estimate:	15.59
Trailing 12 Months:	15.77
PEG Ratio	0.87

EPS Growth
vs. Previous Year	2.00%
vs. Previous Quarter	-10.53%

Sales Growth
vs. Previous Year	3.35%
vs. Previous Quarter:	-1.19%

Price Ratios
Price/Book	8.07
Price/Cash Flow	12.34
Price / Sales	1.18

ROE
09/30/09	68.14
06/30/09	76.53
03/31/09	75.87

ROA
09/30/09	26.51
06/30/09	26.72
03/31/09	28.06

Current Ratio
09/30/09	1.26
06/30/09	1.31
03/31/09	1.13

Quick Ratio
09/30/09	0.62
06/30/09	0.65
03/31/09	0.50

Operating Margin
09/30/09	7.44
06/30/09	7.55
03/31/09	7.92

Net Margin
09/30/09	9.71
06/30/09	9.85
03/31/09	10.50

Pre-Tax Margin
09/30/09	9.71
06/30/09	9.85
03/31/09	10.50

Book Value
09/30/09	4.05
06/30/09	3.44
03/31/09	2.65

Inventory Turnover
09/30/09	3.53
06/30/09	3.64
03/31/09	3.66

Debt-to-Equity
09/30/09	0.27
06/30/09	0.53
03/31/09	0.83

Debt to Capital
09/30/09	21.29
06/30/09	34.79
03/31/09	45.41


About Zacks \| Advertise \| Media \| Careers \| Contact Us \| Help Disclaimer \| Privacy Policy \| Sitemap NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed. Copyright 2009 Zacks Investment Research